← Back to Search

Procedure

LithoVue Elite Ureteroscope for Kidney Stones (LVE Trial)

N/A
Recruiting
Led By Naeem Dr Bhojani, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 18 years
Patient scheduled for ureteroscopy and laser lithotripsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and in the recovery room after surgery
Awards & highlights

LVE Trial Summary

This trial will test a new type of ureteroscope that has pressure-sensing ability. The goal is to see if this new scope can reduce pain and complications related to kidney stones.

Who is the study for?
This trial is for adults over 18 with kidney stones that are not causing a blockage and measure 2 cm or less in total diameter. It's not for those under 18, pregnant individuals, people with unusual kidney shapes, severe swelling of the kidneys, or those who have a tube inserted to drain their kidney.Check my eligibility
What is being tested?
The study is testing the LithoVue Elite ureteroscope—a new disposable scope with pressure sensing abilities—during surgery to remove kidney stones using lasers. The goal is to see how it affects pain levels, quality of life, and risk of infection.See study design
What are the potential side effects?
While specific side effects aren't listed for the device itself, typical risks from ureteroscopy procedures include discomfort during urination, minor bleeding in urine, possible infections and rarely injury to the ureters.

LVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I am scheduled for a procedure to remove kidney stones using lasers.
Select...
I have a kidney stone smaller than 2 cm and am getting a flexible ureteroscopy.

LVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 1-2 weeks after surgery and 4-8 weeks after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 1-2 weeks after surgery and 4-8 weeks after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
WISQOL
Secondary outcome measures
BPI
Change in neutrophil gelatinase-associated lipocalin (NGAL) from baseline
Complications
+2 more

LVE Trial Design

1Treatment groups
Experimental Treatment
Group I: Ureteroscopy (URS) with the LithoVue Elite disposable flexible ureteroscopeExperimental Treatment1 Intervention
Ureteroscopy will be done using the LithoVue Elite disposable flexible ureteroscope instead of the satandard ureteroscope

Find a Location

Who is running the clinical trial?

University of SaskatchewanOTHER
249 Previous Clinical Trials
154,024 Total Patients Enrolled
Laval UniversityOTHER
416 Previous Clinical Trials
172,126 Total Patients Enrolled
Western University, CanadaOTHER
239 Previous Clinical Trials
57,333 Total Patients Enrolled

Media Library

LithoVue 2.0 (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04900688 — N/A
Kidney Stones Research Study Groups: Ureteroscopy (URS) with the LithoVue Elite disposable flexible ureteroscope
Kidney Stones Clinical Trial 2023: LithoVue 2.0 Highlights & Side Effects. Trial Name: NCT04900688 — N/A
LithoVue 2.0 (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04900688 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary goal of this medical experiment?

"The primary objective of this medical trial, which will be evaluated at the conclusion of a surgical procedure, is to measure WISQOL. Additionally, an assessment of Stone free rate through imaging, BPI by means of the Brief Pain Inventory Questionnaire (BPI), and Postoperative infectious Complications as reported by healthcare providers are also monitored for secondary outcomes."

Answered by AI

Are there any vacancies within this clinical trial for participants?

"The entry for this clinical trial on the website of clinicaltrials.gov reveals that recruitment has ceased; it was initially posted on January 15th, 2023 and last updated November 10th 2022. Nevertheless, there are presently 88 other trials actively looking for participants."

Answered by AI

How widespread is the implementation of this experiment?

"This trial is conducted at 6 different sites, with the most prominently being Western University in London, CHU de Québec-Université Laval in Québec City and Hôpital Maisonneuve-Rosemont (HMR) located in Montréal-Est. The remaining 3 locations are less well known."

Answered by AI
Recent research and studies
~69 spots leftby Mar 2025